Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy
Jerry R. Mendell(Nationwide Children's Hospital), David M. Simpson(Icahn School of Medicine at Mount Sinai), W. W. Campbell(Purdue University West Lafayette), Haikady N. Nagaraja(The Ohio State University), Miriam Freimer, Michael E. Shy(University of Iowa Health Care), Richard Rice, Michael H. Rivner, Catherine A. Thornton(Swansea University), Maurizio Giuliani, Rebecca Lewis, Rup Tandan, Gareth Parry(Cambridge Health Alliance), Charles E. Jackson, P. D. Donofrio, J. T. Kissel, Mark B. Bromberg(American Academy of Neurology), Richard J. Barohn(University of Missouri Health System), Yadollah Harati(Baylor College of Medicine), Wendy King(The Ohio State University)
Cited by 309
Related Papers
Evidence‐based path to newborn screening for duchenne muscular dystrophy
|Annals of Neurology|2012|816
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793
Dystrophin Immunity in Duchenne's Muscular Dystrophy
|New England Journal of Medicine|2010|655
Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease
|Medicine & Science in Sports & Exercise|2019|652